NCT03843359 2026-01-08A First Time in Human (FTIH) Study of GSK3745417 Administered to Participants With Advanced Solid TumorsGlaxoSmithKlinePhase 1 Active not recruiting97 enrolled 45 charts
NCT02817633 2025-10-28A Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER)Tesaro, Inc.Phase 1 Active not recruiting463 enrolled
NCT04446351 2025-10-27Study of the Safety and Effectiveness of GSK6097608 in Participants With Advanced Solid TumorsGlaxoSmithKlinePhase 1 Active not recruiting107 enrolled